查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1737603

微創椎間設備的全球市場:規模，佔有率，趨勢分析(2025年～2031年):MedCore(MIPLIF，MITLIF，其他)

MIS Interbody Devices Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: MIPLIF Market, MITLIF Market, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 97 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

側入路腰椎椎間融合術 (LLIF) 是 2024 年市場上最大的細分領域。 MIPLIF 是成長最快的，預計所有細分領域的價值都將繼續成長。另一方面，MIPLIF 由於價格大幅下降，市場佔有率最小。

本報告涵蓋了微創椎間融合術的細分領域，例如微創腰椎椎間融合術 (MIPLIF)、微創經腰椎椎間融合術 (MITLIF)、側入路腰椎椎間融合術 (LLIF) 和斜入路側入路椎間融合術 (OLIF)。

本報告包​​含來自七個不同地區 65 多個國家的數據。這些地區包括北美、拉丁美洲、西歐、中歐和東歐、中東、亞太地區和非洲。

市場報告資料型態

  • 銷售量、平均售價、市場規模與成長趨勢
  • 手術數量
  • 市場推動因素與阻礙因素
  • 2031 年市場預測，2024 年歷史數據
  • 近期併購
  • 公司簡介與產品組合
  • 主要競爭對手

全球微創椎間裝置市場趨勢

  • 該市場的主要推動因素是老年人口相對於年輕人口的增長，以及患者和外科醫生越來越傾向於微創手術，因為此類手術恢復時間更短，對肌肉和組織的損傷更小。

全球市場佔有率的洞察

Globus Medical/NuVasive

  • MIS椎間融合器市佔率領先
  • 2023年初合併增強實力
  • 北美、西歐及世界其他地區市佔率領先

美敦力

  • 市場第二大競爭對手。
  • 直接側方椎間融合術 (DLIF®) 嶄露頭角
  • 所有地區市佔率第二

DePuy Synthes

  • 全球第三大競爭對手
  • 未來成長取決於微創外科 (MIS) 市場的創新
  • 所有地區排名第三

範圍摘要

目標地區

  • 北美(加拿大，美國)
  • 南美(阿根廷，玻利維亞，巴西，智利，哥倫比亞，哥斯大黎加，多明尼加共和國，厄瓜多，瓜地馬拉，墨西哥，巴拿馬，巴拉圭，秘魯，波多黎各，烏拉圭，委內瑞拉)
  • 西歐(奧地利，荷比盧三國，法國，德國，義大利，葡萄牙，斯堪地那維亞，西班牙，瑞士，英國)
  • 中東歐(亞塞拜然，波羅的海國家，白俄羅斯，保加利亞，克羅埃西亞，捷克，喬治亞，希臘，匈牙利，哈薩克，波蘭，羅馬尼亞，俄羅斯，塞爾維亞，斯洛伐克，斯洛維尼亞，土耳其，烏克蘭)
  • 中東(巴林，伊朗，以色列，科威特，阿曼，卡達，沙烏地阿拉伯，阿拉伯聯合大公國)
  • 亞太地區(澳洲，柬埔寨，中國，香港，印度，印尼，日本，吉爾吉斯，澳門，馬來西亞，蒙古，緬甸，紐西蘭，巴基斯坦，菲律賓，新加坡，韓國，斯里蘭卡，台灣，泰國，烏茲別克，越南)
  • 非洲(阿爾及利亞，埃及，衣索比亞，迦納，肯亞，利比亞，摩洛哥，奈及利亞，南非，蘇丹，烏干達)

基準年:2024年

預測期間:2025年～2031年

過去資料:2021年～2023年

定量資料

  • 市場規模
  • 市場佔有率
  • 市場預測
  • 市場成長率
  • 銷售台數
  • 平均銷售價格

定性的資料

  • 市場成長趨勢
  • 市場限制器
  • 競爭分析及龍頭企業的SWOT
  • 合併和收購
  • 企業簡介
  • 產品系列
  • FDA回收
  • 顛覆性技術
  • 疾病概要

資料來源

  • 對產業領導者的一次採訪
  • 政府醫生資料
  • 法規資料
  • 醫院資料
  • 進出口資料
  • 公司內部資料庫

本報告提供全球微創椎間設備市場相關調查，市場概要，以及市場分析與預測，促進因素與阻礙因素，競爭情形等資訊。

目錄

微創椎間設備市場

  • 摘要整理
    • 全球MIS椎間設備市場概要
    • 競爭分析
    • 手術的市場區隔
    • 市場區隔
    • 對象地區
  • 簡介
  • 手術數量
    • MIPLIF手術
    • MITLIF手術
    • LLIF手術
    • OLIF手術
  • 市場概要
    • 各市場區隔
    • 各地區
  • 市場分析與預測
    • MIS椎間設備市場全體
    • MIPLIF市場
    • MITLIF市場
    • LLIF市場
    • OLIF市場
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析
Product Code: iDATA_GLMIS25_MC_ID

The largest subsegment of this market in 2024 was the lateral lumbar interbody fusion (LLIF). It is expected that all subsegments keep growing in value with the MIPLIF being the fastest growing. On the other hand, MIPLIF has the smallest market value share because of a high decline in prices.

The full report suite on the global market for MIS interbody devices includes subsegments for the minimally invasive interbody devices such as minimally invasive posterior lumbar interbody fusion (MIPLIF), minimally invasive transforaminal lumbar interbody fusion (MITLIF), lateral lumbar interbody fusion (LLIF) and oblique lateral interbody (OLIF).

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2024
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitor

GLOBAL MIS INTERBODY DEVICE MARKET TRENDS

  • The major driver of this market is the increase in the elderly population relative to younger demographics and the tendency of the patients and surgeons for less invasive surgeries, as they result in less recovery time and less damage to the muscles and tissues.

Global Market Share Insights

1. 1. Globus Medical / NuVasive

  • Leading competitor in the total MIS interbody device market.
  • Strengthened by the merger in early 2023.
  • Held leading share in North America, Western Europe and Rest of the World.

2. 2. Medtronic

  • Second leading competitor in the market.
  • Presence supported by Direct Lateral Interbody Fusion (DLIF(R)).
  • Held second-largest share in all regions reported.

3. 3. DePuy Synthes

  • Third-leading competitor globally.
  • Future growth depends on innovation in the MIS market.
  • Held third position in all regions reported.

Research Scope Summary

Regions

  • North America (Canada, United States)
  • Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
  • Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
  • Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
  • Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
  • Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
  • Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2024

Forecast Period: 2025-2031

Historical Data: 2021-2023

Quantitative Data

  • Market Size
  • Market Shares
  • Market Forecasts
  • Market Growth Rates
  • Units Sold
  • Average Selling Prices

Qualitative Data

  • Market Growth Trends
  • Market Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles
  • Product Portfolios
  • FDA Recalls
  • Disruptive Technologies
  • Disease Overviews

Data Sources

  • Primary Interviews with Industry Leaders
  • Government Physician Data
  • Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

MIS Interbody Device Market

  • 4.1 Executive Summary
    • 4.1.1 Global MIS Interbody Device Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Procedure Segmentation
    • 4.1.4 Market Segmentation
    • 4.1.5 Regions Included
  • 4.2 Introduction
      • 4.2.1.1 Minimally Invasive Posterior Lumbar Interbody Fusion
      • 4.2.1.2 Minimally Invasive Transforaminal Lumbar Interbody Fusion
      • 4.2.1.3 Lateral Lumbar Interbody Fusion
      • 4.2.1.4 Direct Lateral Interbody Fusion
      • 4.2.1.5 eXtreme Lateral Interbody Fusion
      • 4.2.1.6 Guided Lateral Interbody Fusion
      • 4.2.1.7 Oblique Lateral Interbody Fusion
  • 4.3 Procedure Numbers
    • 4.3.1 MIPLIF Procedures
    • 4.3.2 MITLIF Procedures
    • 4.3.3 LLIF Procedures
    • 4.3.4 OLIF Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Region
  • 4.5 Market Analysis and Forecast
    • 4.5.1 Total MIS Interbody Device Market
    • 4.5.2 MIPLIF Market
    • 4.5.3 MITLIF Market
    • 4.5.4 LLIF Market
    • 4.5.5 OLIF Market
  • 4.6 Drivers and Limiters
    • 4.6.1 Market Drivers
    • 4.6.2 Market Limiters
  • 4.7 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 4-1: MIS Interbody Device Market, Global, 2024 & 2031
  • Chart 4-2: MIS Interbody Device Procedures, Global, 2024
  • Chart 4-3: MIS Interbody Device Procedures by Segment, Global, 2021 - 2031
  • Chart 4-4: MIS Interbody Device Market by Segment, Global, 2021 - 2031
  • Chart 4-5: MIS Interbody Device Market by Region, Global, 2021 - 2031
  • Chart 4-6: Leading Competitors, MIS Interbody Fusion Market, Global, 2024

LIST OF FIGURES

  • Figure 4-1: MIS Interbody Device Procedure Segmentation
  • Figure 4-2: MIS Interbody Device Market Segmentation
  • Figure 4-3: MIS Interbody Device Regions Covered, Global (1 of 2)
  • Figure 4-4: MIS Interbody Device Regions Covered (2 of 2)
  • Figure 4-5: MIS Interbody Device Procedures by Segment, Global, 2021 - 2031
  • Figure 4-6: MIS Interbody Device Procedures by Region, Global, 2021 - 2031
  • Figure 4-7: MIS Interbody Device Procedures by Country, North America, 2021 - 2031
  • Figure 4-8: MIS Interbody Device Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-9: MIS Interbody Device Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-10: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-11: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-12: MIS Interbody Device Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-13: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-14: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-15: MIS Interbody Device Procedures by Country, Africa, 2021 - 2031
  • Figure 4-16: MIPLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-17: MIPLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-18: MIPLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-19: MIPLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-20: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-21: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-22: MIPLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-23: MIPLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-24: MIPLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-25: MIPLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-26: MITLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-27: MITLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-28: MITLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-29: MITLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-30: MITLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-31: MITLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-32: MITLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-33: MITLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-34: MITLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-35: MITLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-36: LLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-37: LLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-38: LLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-39: LLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-40: LLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-41: LLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-42: LLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-43: LLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-44: LLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-45: LLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-46: OLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-47: OLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-48: OLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-49: OLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-50: OLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-51: OLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-52: OLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-53: OLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-54: OLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-55: OLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-56: MIS Interbody Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 4-57: MIS Interbody Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 4-58: MIS Interbody Device Market, Global, 2021 - 2031
  • Figure 4-59: Units Sold by Region, MIS Interbody Device Market, Global, 2021 - 2031
  • Figure 4-60: Average Selling Price by Region, MIS Interbody Device Market, Global, 2021 - 2031 (US$)
  • Figure 4-61: Market Value by Region, MIS Interbody Device Market, Global, 2021 - 2031 (US$M)
  • Figure 4-62: MIPLIF Market, Global, 2021 - 2031
  • Figure 4-63: Units Sold by Region, MIPLIF Market, Global, 2021 - 2031
  • Figure 4-64: Average Selling Price by Region, MIPLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-65: Market Value by Region, MIPLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-66: MITLIF Market, Global, 2021 - 2031
  • Figure 4-67: Units Sold by Region, MITLIF Market, Global, 2021 - 2031
  • Figure 4-68: Average Selling Price by Region, MITLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-69: Market Value by Region, MITLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-70: LLIF Market, Global, 2021 - 2031
  • Figure 4-71: Units Sold by Region, LLIF Market, Global, 2021 - 2031
  • Figure 4-72: Average Selling Price by Region, LLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-73: Market Value by Region, LLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-74: OLIF Market, Global, 2021 - 2031
  • Figure 4-75: Units Sold by Region, OLIF Market, Global, 2021 - 2031
  • Figure 4-76: Average Selling Price by Region, OLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-77: Market Value by Region, OLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-78: Leading Competitors, MIS Interbody Fusion Market, Global, 2024